Motif ID: REL
Z-value: 1.179
Transcription factors associated with REL:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
REL | ENSG00000162924.9 | REL |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
REL | hg19_v2_chr2_+_61108650_61108687 | 0.39 | 6.0e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
1.1 | 3.2 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.8 | 1.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.7 | 2.2 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.6 | 12.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 2.1 | GO:0044805 | late nucleophagy(GO:0044805) |
0.5 | 1.6 | GO:0070428 | B-1 B cell homeostasis(GO:0001922) toll-like receptor 5 signaling pathway(GO:0034146) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.5 | 1.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.4 | 1.8 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.4 | 2.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.3 | 2.9 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 2.1 | GO:2000669 | positive regulation of pinocytosis(GO:0048549) negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.3 | 8.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 2.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.3 | 1.1 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 1.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 0.9 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 0.7 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.2 | 1.8 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.2 | 1.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 3.1 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.8 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.2 | 0.8 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.2 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.2 | 1.1 | GO:0036337 | Fas signaling pathway(GO:0036337) necroptotic signaling pathway(GO:0097527) |
0.2 | 0.7 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.2 | 0.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 2.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.4 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 1.4 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.4 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 0.5 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 1.0 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.5 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 2.9 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.5 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.3 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.1 | 0.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 1.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.3 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 1.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.1 | 2.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.1 | 0.2 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.5 | GO:0030805 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.2 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 0.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.3 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 1.0 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 2.2 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 1.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.6 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 0.3 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.4 | GO:1904417 | negative regulation of receptor recycling(GO:0001920) regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 1.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.4 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.1 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.0 | 0.2 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.0 | 1.0 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.2 | GO:0046013 | interleukin-2-mediated signaling pathway(GO:0038110) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.3 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.4 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.4 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 1.0 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.0 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.9 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 1.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.4 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.0 | 0.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 1.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.5 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.0 | 0.1 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.0 | 0.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.2 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.0 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.0 | 2.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 1.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 8.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.7 | 2.1 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.8 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 1.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.2 | 3.1 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 1.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 0.8 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 2.1 | GO:0033643 | host cell part(GO:0033643) |
0.1 | 0.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 1.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.5 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 1.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 3.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 2.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 3.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 1.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 1.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 13.4 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.3 | GO:0005938 | cell cortex(GO:0005938) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.6 | 3.0 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.6 | 2.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 2.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 3.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 0.8 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.3 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.7 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.2 | 1.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.7 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.2 | 1.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 1.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 2.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 1.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 3.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 2.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.3 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.1 | 0.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.5 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 0.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.5 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 0.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 1.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 1.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.9 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 13.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 1.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.1 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 8.7 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 12.6 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
0.1 | 4.1 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 7.3 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.1 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.7 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 3.8 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
0.1 | 3.4 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.2 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.5 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.1 | PID_REELIN_PATHWAY | Reelin signaling pathway |
0.0 | 0.6 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.0 | 1.0 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.0 | 0.7 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 2.3 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
0.0 | 2.1 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.4 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.6 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.7 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.3 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.0 | 0.4 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.0 | 5.7 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.2 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.7 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.7 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.5 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 3.8 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 3.9 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 2.2 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.8 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 3.9 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 9.9 | REACTOME_CELL_JUNCTION_ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.5 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.8 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 4.5 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.4 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.0 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.2 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.9 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.7 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.8 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.7 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.5 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.2 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 2.6 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.7 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.5 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.3 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 2.0 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |